- Home
- WPC vs NBIX Comparison
WPC vs NBIX Comparison
Compare WPC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPC
- NBIX
- Stock Information
- Founded
- WPC 1973
- NBIX 1992
- Country
- WPC United States
- NBIX United States
- Employees
- WPC N/A
- NBIX N/A
- Industry
- WPC Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WPC Real Estate
- NBIX Health Care
- Exchange
- WPC Nasdaq
- NBIX Nasdaq
- Market Cap
- WPC 13.7B
- NBIX 12.4B
- IPO Year
- WPC 1998
- NBIX 1996
- Fundamental
- Price
- WPC $61.68
- NBIX $132.02
- Analyst Decision
- WPC Hold
- NBIX Strong Buy
- Analyst Count
- WPC 13
- NBIX 21
- Target Price
- WPC $93.08
- NBIX $165.14
- AVG Volume (30 Days)
- WPC 1.2M
- NBIX 822.0K
- Earning Date
- WPC 07-29-2025
- NBIX 07-30-2025
- Dividend Yield
- WPC 5.78%
- NBIX N/A
- EPS Growth
- WPC N/A
- NBIX N/A
- EPS
- WPC 1.94
- NBIX 2.96
- Revenue
- WPC $1,595,990,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- WPC $4.80
- NBIX $16.25
- Revenue Next Year
- WPC $5.57
- NBIX $15.23
- P/E Ratio
- WPC $31.72
- NBIX $44.51
- Revenue Growth
- WPC N/A
- NBIX 21.73
- 52 Week Low
- WPC $52.91
- NBIX $84.23
- 52 Week High
- WPC $66.10
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- WPC 44.26
- NBIX 57.42
- Support Level
- WPC $61.09
- NBIX $131.07
- Resistance Level
- WPC $63.88
- NBIX $135.70
- Average True Range (ATR)
- WPC 1.06
- NBIX 3.22
- MACD
- WPC -0.19
- NBIX -0.01
- Stochastic Oscillator
- WPC 21.15
- NBIX 60.94
About WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.